GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Financiere de Tubize SA (LTS:0D53) » Definitions » Book Value per Share

Financiere de Tubize (LTS:0D53) Book Value per Share : €40.36 (As of Dec. 2023)


View and export this data going back to 2007. Start your Free Trial

What is Financiere de Tubize Book Value per Share?

Financiere de Tubize's book value per share for the quarter that ended in Dec. 2023 was €40.36.

During the past 12 months, Financiere de Tubize's average Book Value Per Share Growth Rate was 2.60% per year. During the past 3 years, the average Book Value Per Share Growth Rate was -13.70% per year. During the past 5 years, the average Book Value Per Share Growth Rate was -10.10% per year. During the past 10 years, the average Book Value Per Share Growth Rate was 1.50% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the book value growth rate using book value per share data.

During the past 13 years, the highest 3-Year average Book Value Per Share Growth Rate of Financiere de Tubize was 57.30% per year. The lowest was -13.90% per year. And the median was 4.45% per year.

Financiere de Tubize's current price is €105.40. Its book value per share for the quarter that ended in Dec. 2023 was €40.36. Hence, today's PB Ratio of Financiere de Tubize is 2.61.

During the past 13 years, the highest P/B Ratio of Financiere de Tubize was 2.79. The lowest was 0.00. And the median was 0.00.


Financiere de Tubize Book Value per Share Historical Data

The historical data trend for Financiere de Tubize's Book Value per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Financiere de Tubize Book Value per Share Chart

Financiere de Tubize Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Book Value per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 59.86 62.74 38.30 39.35 40.36

Financiere de Tubize Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Book Value per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 38.30 78.20 39.35 41.40 40.36

Competitive Comparison of Financiere de Tubize's Book Value per Share

For the Biotechnology subindustry, Financiere de Tubize's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Financiere de Tubize's PB Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Financiere de Tubize's PB Ratio distribution charts can be found below:

* The bar in red indicates where Financiere de Tubize's PB Ratio falls into.



Financiere de Tubize Book Value per Share Calculation

Financiere de Tubize's Book Value Per Share for the fiscal year that ended in Dec. 2023 is calculated as:

Book Value Per Share=(Total Stockholders Equity-Preferred Stock)/Shares Outstanding (EOP)
=(1,796.59-0.00)/44.51
=40.36

Financiere de Tubize's Book Value Per Share for the quarter that ended in Dec. 2023 is calculated as:

Book Value Per Share=(Total Stockholders Equity-Preferred Stock)/Shares Outstanding (EOP)
=(1,796.59-0.00)/44.51
=40.36

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Theoretically it is what the shareholders will receive if the company is liquidated. Total Stockholders Equity is a balance sheet item and equal to Total Assets less Total Liabilities of the company.

Book value may include intangible items which may come from the company's past acquisitions. Book value less intangibles is called Tangible Book.


Financiere de Tubize  (LTS:0D53) Book Value per Share Explanation

Usually a company's book value and Tangible Book per Share may not reflect its true value. The assets may be carried on the balance sheets at the original cost minus depreciation. This may underestimate the true economic values of the assets. It also may over-estimate their true economic value because the assets can become obsolete.

For financial companies such as banks and insurance companies, their assets may be reported in current market value of the assets owned. Book values of financial companies are more accurate indicator of the economic value of the company.


Financiere de Tubize Book Value per Share Related Terms

Thank you for viewing the detailed overview of Financiere de Tubize's Book Value per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Financiere de Tubize (LTS:0D53) Business Description

Traded in Other Exchanges
Address
Allée de la Recherche, 60, Brussels, BEL, 1070
Financiere de Tubize SA is a holding company that owns a stake in UCB, a biopharmaceutical company. UCB is a global biotechnology company that develops treatments for conditions related to neurology and immunology. UCB generates the vast majority of its revenue in the United States, followed by Europe and other international markets. Most of its sales revenue is derived from its neurology products, followed by its immunology products. The company's strategy focuses on leveraging scientific advances and skills in areas such as genetics, biomarkers, and human biology.

Financiere de Tubize (LTS:0D53) Headlines

No Headlines